<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03001921</url>
  </required_header>
  <id_info>
    <org_study_id>WISHES</org_study_id>
    <nct_id>NCT03001921</nct_id>
  </id_info>
  <brief_title>Wise Practice of Chinese Hemodialysis (WISHES)</brief_title>
  <official_title>Wise Practice of Chinese Hemodialysis (WISHES)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are registering all HD patients at recruited hospitals and developing a HD
      database in China. Patients will be follow-up every 3 months, and both baseline and follow-up
      information will be entered into the registration system. The patient survival, technical
      survival, patency rate of access, quality of life and residual renal function for HD patients
      will be compared using the HD database.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators are registering all end stage renal disease (ESRD) patients receiving
      hemodialysis (HD) treatment, and developing a HD database in China. Patients' demographic
      characteristics (including age, gender, height, weight, BMI, smoking, drinking, and
      education), clinical characteristics (including systolic blood pressure, diastolic blood
      pressure, primary cause of ESRD, and lab measurements of serum, urine, and access patency),
      complications, drug information and scores of quality of life at the baseline will be
      collected. Patients will be follow-up every 3 month, the demographic and clinical
      characteristics, complications and drug information of patients will be collected at each
      visit. The investigators also record the outcome at each visit, such as mortality (including
      all-cause mortality and cardiovascular disease mortality), technical survival, kidney
      transplantation, transfer to peritoneal dialysis, hospitalization, access failureï¼Œetc. The
      patient survival, technical survival, patency rate of access, quality of life and residual
      renal function for HD patients will be compared using the HD database.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2027</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Patient survival of HD patients</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life evaluated using SF36 scale for HD patients</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patency rate of access for HD patients</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30000</enrollment>
  <condition>Haemolyses and Related Conditions</condition>
  <arm_group>
    <arm_group_label>Hemodialysis patients</arm_group_label>
    <description>End stage renal disease patients receiving hemodialysis treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>Registration of all HD patients in the First Affiliated Hospital of Sun Yat-sen University and other hospital which have signed the contract in China.</description>
    <arm_group_label>Hemodialysis patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      he serum, urine, and DNA will be collected.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        End stage renal disease patients receiving hemodialysis treatment
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        End stage renal disease patients receiving hemodialysis treatment.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xueqing Yu, M.D. &amp; Ph.D.</last_name>
    <email>yuxq@mail.sysu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xunhua Zheng, M.D. &amp; Ph.D.</last_name>
    <email>wilson_zxh@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The 1st Affiliated Hospital, Sun Yet-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xueqing Yu, M.D. &amp; Ph.D.</last_name>
      <email>yuxq@mail.sysu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Xueqing Yu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2016</study_first_submitted>
  <study_first_submitted_qc>December 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2016</study_first_posted>
  <last_update_submitted>January 21, 2018</last_update_submitted>
  <last_update_submitted_qc>January 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Xue Qing Yu</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Hemodialysis</keyword>
  <keyword>Patient survival</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Hemodialysis access</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemolysis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

